Journalartikel

IMMUNE PHAGOCYTOSIS INHIBITION BY COMMERCIAL IMMUNOGLOBULINS


AutorenlisteNEPPERT, J; CLEMENS, M; MUELLERECKHARDT, C

Jahr der Veröffentlichung1986

Seiten67-72

ZeitschriftBlut

Bandnummer52

Heftnummer2

ISSN0006-5242

Open Access StatusBronze

DOI Linkhttps://doi.org/10.1007/BF00321069

VerlagSpringer


Abstract
Sixteen commercially available immunoglobulins (Ig) and 5 anti-Rho(D) hyperimmune globulins were investigated for immune phagocytosis inhibition (IPI) factors as well as for T, B lymphocytotoxic and monocytotoxic antibodies. All Ig contained IPI factors with lowest inhibitory IgG concentrations ranging from 0.08 to 50 mg/ml. Pepsin-digested Ig was noninhibitory. IPI factors in anti-D preparations were uniformly high (inhibitory IgG concentrations 0.6-2.5 mg/ml). Cytotoxic antibodies against T, B lymphocytes and monocytes were found in 2,2 and 7 products, respectively. Since we have recently shown that IPI is caused by antibodies against major histocompatibility complex antigens, most likely HLA, the hypothesis is put forward that IPI factors in Ig are HLA-related, cytotoxic as well as noncytotoxic antibodies which act via Fc receptor blockade of human monocytes.



Zitierstile

Harvard-ZitierstilNEPPERT, J., CLEMENS, M. and MUELLERECKHARDT, C. (1986) IMMUNE PHAGOCYTOSIS INHIBITION BY COMMERCIAL IMMUNOGLOBULINS, Blut, 52(2), pp. 67-72. https://doi.org/10.1007/BF00321069

APA-ZitierstilNEPPERT, J., CLEMENS, M., & MUELLERECKHARDT, C. (1986). IMMUNE PHAGOCYTOSIS INHIBITION BY COMMERCIAL IMMUNOGLOBULINS. Blut. 52(2), 67-72. https://doi.org/10.1007/BF00321069


Zuletzt aktualisiert 2025-10-06 um 12:14